Request for Covid-19 Impact Assessment of this Report

Pharmaceuticals

Worldwide Fabry Disease Therapeutic Market Research Report 2021 by Type, Application, Participants and Countries, COVID-19 Impact, Forecast Year to 2026

  • PRO4493454
  • 126 Pages
  • May 2021
  • Pharmaceuticals
Download Sample    Get Discount   
 
Due to the high popularity of this product/service in North America and Asia, the growth trend of Fabry Disease Therapeutic in recent years and the growth of consumers' demand is expected to drive the global Fabry Disease Therapeutic market.

Geographically, the global Fabry Disease Therapeutic market is divided into North America, Europe, Latin America, Asia Pacific, Middle East & Africa.

North America, Asia and Europe have significant position in the this market, big players operating in there. The U.S. is accounting for a major share of the total Fabry Disease Therapeutic market in North America.

Significant participants active in the global Fabry Disease Therapeutic market include: Bristol-Myers Squibb Company, AbbVie Inc., Takeda Pharmaceutical Co. Ltd., Shire, Green Cross Corp., Protalix, Amicus therapeutics, Amgen Inc., Sanofi-Aventis LLC, Merck & Co., GlaxoSmithKline plc, Genzyme-Sanofi, Pfizer, Teva pharmaceutical Industries Ltd., Novartis Pharmaceuticals...

Global Fabry Disease Therapeutic Market Segmentation:

Fabry Disease Therapeutic market, by Fabry Disease Therapeutic type:

Enzyme Replacement Therapy

Alternative therapies

Fabry Disease Therapeutic market, by Application:

Hospitals

Clinics

Others

Fabry Disease Therapeutic Market Research Report 2014-2026, by region:

North America

The U.S.

Canada

Europe

Germany

UK

France

Italy

Spain

Rest of Europe

Latin America

Mexico

Brazil

Argentina

Pan Asia Pacific

China

Japan

South Korea

South East Asia Region

India

Australia

Middle East and Africa

Saudi Arabia

UAE

Qatar

Egypt

Nigeria

South Africa

Rest of MEA

The database is running updated by a group of research experts to always reflect the latest trends and information.

Table of Content

1. Introduction

1.1 Definition of the Market

1.2 Research Purpose

1.3 Scope of the Study

1.4 Stakeholders

1.5 Geography Coverage

1.6 Currency Under Consideration

1.7 Volume Units

1.8 Review Cycle

1.9 Summary and Key Findings of the Research

2 Research Methodology

2.1 Research Data

2.1.1 Secondary Data

2.1.2 Primary Data

2.2 Market Size Estimation

2.2.1 Bottom-Up Approach

2.2.2 Top-Down Approach (Involves time, Space, and Persons)

2.3 Data Triangulation

2.4 Assumptions

2.5 Hypothesis of this Research, Clear, Specific, and Testable Statement of This Research

2.6 Limitations of Our Study

2.7 Scene Based Modeling

2.8 Covid-19 Impact/Evaluation

3. Market Dynamics

3.1 Driving Factors

3.1.1 Rising Demand in one or More of the Following Regions: North America, Europe, Asia-Pacific, Latin America, Middle East & Africa

3.1.2 Increasing Use of Fabry Disease Therapeutic by Different End-User/Applications

3.2 Restraints and Challenges in the Market

3.3 Opportunities

4. Global Fabry Disease Therapeutic Market-Segmentation

4.1 By Type

4.1.1 Enzyme Replacement Therapy

4.1.2 Alternative therapies

4.2 By End-User/Application Industry

4.2.1 Hospitals

4.2.2 Clinics

4.2.3 Others

4.3 By Geography

4.3.1 North America Fabry Disease Therapeutic Total Market Size (Production, Consumption, Import, Export) and Segmentation (by Type, Application, Countries and Participants)

4.3.1.1 North America Fabry Disease Therapeutic Production from 2014-2020

4.3.1.2 North America Fabry Disease Therapeutic Consumption from 2014-2020

4.3.1.3 North America Fabry Disease Therapeutic Import and Export from 2014-2020

4.3.1.4 North America Fabry Disease Therapeutic Market Value ($) and Growth (%) by Type from 2019-2020

4.3.1.5 North America Fabry Disease Therapeutic Market Value ($) and Growth (%) by Application from 2019-2020

4.3.1.6 North America Fabry Disease Therapeutic Market Value ($) and Growth (%) by Countries from 2019-2020

4.3.1.7 Top North America Fabry Disease Therapeutic Participants Value ($) and Market Share (%) in 2019

4.3.2 Europe Fabry Disease Therapeutic Total Market Size (Production, Consumption, Import, Export) and Segmentation (by Type, Application, Countries and Participants)

4.3.2.1 Europe Fabry Disease Therapeutic Production from 2014-2020

4.3.2.2 Europe Fabry Disease Therapeutic Consumption from 2014-2020

4.3.2.3 Europe Fabry Disease Therapeutic Import and Export from 2014-2020

4.3.2.4 Europe Fabry Disease Therapeutic Market Value ($) and Growth (%) by Type from 2019-2020

4.3.2.5 Europe Fabry Disease Therapeutic Value ($) and Growth (%) by Application from 2019-2020

4.3.2.6 Europe Fabry Disease Therapeutic Market Value ($) and Growth (%) by Countries from 2019-2020

4.3.2.7 Top Europe Fabry Disease Therapeutic Participants Value ($) and Market Share (%) in 2019

4.3.3 Asia-Pacific Fabry Disease Therapeutic Total Market Size (Production, Consumption, Import, Export) and Segmentation (by Type, Application, Countries and Participants)

4.3.3.1 Asia-Pacific Fabry Disease Therapeutic Production from 2014-2020

4.3.3.2 Asia-Pacific Fabry Disease Therapeutic Consumption from 2014-2020

4.3.3.3 Asia-Pacific Fabry Disease Therapeutic Import and Export from 2014-2020

4.3.3.4 Asia-Pacific Fabry Disease Therapeutic Value ($) and Growth (%) by Type from 2019-2020

4.3.3.5 Asia-Pacific Fabry Disease Therapeutic Value ($) and Growth (%) by Application from 2019-2020

4.3.3.6 Asia-Pacific Fabry Disease Therapeutic Value ($) and Growth (%) by Countries from 2019-2020

4.3.3.7 Top Asia-Pacific Fabry Disease Therapeutic Participants Value ($) and Market Share (%) in 2019

4.3.4 Latin America Fabry Disease Therapeutic Total Market Size (Production, Consumption, Import, Export) and Segmentation (by Type, Application, Countries and Participants)

4.3.4.1 Latin America Fabry Disease Therapeutic Production from 2014-2020

4.3.4.2 Latin America Fabry Disease Therapeutic Consumption from 2014-2020

4.3.4.3 Latin America Fabry Disease Therapeutic Import and Export from 2014-2020

4.3.4.4 Latin America Fabry Disease Therapeutic Value ($) and Growth (%) by Type from 2019-2020

4.3.4.5 Latin America Fabry Disease Therapeutic Value ($) and Growth (%) by Application from 2019-2020

4.3.4.6 Latin America Fabry Disease Therapeutic Value ($) and Growth (%) by Countries from 2019-2020

4.3.4.7 Top Latin America Fabry Disease Therapeutic Participants Value ($) and Market Share (%) in 2019

4.3.5 Middle East & Africa Fabry Disease Therapeutic Total Market Size (Production, Consumption, Import, Export) and Segmentation (by Type, Application, Countries and Participants)

4.3.5.1 Middle East & Africa Fabry Disease Therapeutic Production from 2014-2020

4.3.5.2 Middle East & Africa Fabry Disease Therapeutic Consumption from 2014-2020

4.3.5.3 Middle East & Africa Fabry Disease Therapeutic Import and Export from 2014-2020

4.3.5.4 Middle East & Africa Fabry Disease Therapeutic Value ($) and Growth (%) by Type from 2019-2020

4.3.5.5 Middle East & Africa Fabry Disease Therapeutic Value ($) and Growth (%) by Application from 2019-2020

4.3.5.6 Middle East & Africa Fabry Disease Therapeutic Value ($) and Growth (%) by Countries from 2019-2020

4.3.5.7 Top Middle East & Africa Fabry Disease Therapeutic Participants Value ($) and Market Share (%) in 2019

5. Competitive Intelligence – Company Profiles

5.1 Bristol-Myers Squibb Company

5.1.1 Bristol-Myers Squibb Company Company Profile (Company Name, Major Business, Plants Distribution, Sales Region, Contact Information)

5.1.2 Bristol-Myers Squibb Company Sales, Growth Rate and Global Market Share from 2014-2020

5.2 AbbVie Inc.

5.2.1 AbbVie Inc. Company Profile (Company Name, Major Business, Plants Distribution, Sales Region, Contact Information)

5.2.2 AbbVie Inc. Sales, Growth Rate and Global Market Share from 2014-2020

5.3 Takeda Pharmaceutical Co. Ltd.

5.3.1 Takeda Pharmaceutical Co. Ltd. Company Profile (Company Name, Major Business, Plants Distribution, Sales Region, Contact Information)

5.3.2 Takeda Pharmaceutical Co. Ltd. Sales, Growth Rate and Global Market Share from 2014-2020

5.4 Shire

5.4.1 Shire Company Profile (Company Name, Major Business, Plants Distribution, Sales Region, Contact Information)

5.4.2 Shire Sales, Growth Rate and Global Market Share from 2014-2020

5.5 Green Cross Corp.

5.5.1 Green Cross Corp. Company Profile (Company Name, Major Business, Plants Distribution, Sales Region, Contact Information)

5.5.2 Green Cross Corp. Sales, Growth Rate and Global Market Share from 2014-2020

5.6 Protalix

5.6.1 Protalix Company Profile (Company Name, Major Business, Plants Distribution, Sales Region, Contact Information)

5.6.2 Protalix Sales, Growth Rate and Global Market Share from 2014-2020

5.7 Amicus therapeutics

5.7.1 Amicus therapeutics Company Profile (Company Name, Major Business, Plants Distribution, Sales Region, Contact Information)

5.7.2 Amicus therapeutics Sales, Growth Rate and Global Market Share from 2014-2020

5.8 Amgen Inc.

5.8.1 Amgen Inc. Company Profile (Company Name, Major Business, Plants Distribution, Sales Region, Contact Information)

5.8.2 Amgen Inc. Sales, Growth Rate and Global Market Share from 2014-2020

5.9 Sanofi-Aventis LLC

5.9.1 Sanofi-Aventis LLC Company Profile (Company Name, Major Business, Plants Distribution, Sales Region, Contact Information)

5.9.2 Sanofi-Aventis LLC Sales, Growth Rate and Global Market Share from 2014-2020

5.10 Merck & Co.

5.10.1 Merck & Co. Company Profile (Company Name, Major Business, Plants Distribution, Sales Region, Contact Information)

5.10.2 Merck & Co. Sales, Growth Rate and Global Market Share from 2014-2020

5.11 GlaxoSmithKline plc

5.11.1 GlaxoSmithKline plc Company Profile (Company Name, Major Business, Plants Distribution, Sales Region, Contact Information)

5.11.2 GlaxoSmithKline plc Sales, Growth Rate and Global Market Share from 2014-2020

5.12 Genzyme-Sanofi

5.12.1 Genzyme-Sanofi Company Profile (Company Name, Major Business, Plants Distribution, Sales Region, Contact Information)

5.12.2 Genzyme-Sanofi Sales, Growth Rate and Global Market Share from 2014-2020

5.13 Pfizer

5.13.1 Pfizer Company Profile (Company Name, Major Business, Plants Distribution, Sales Region, Contact Information)

5.13.2 Pfizer Sales, Growth Rate and Global Market Share from 2014-2020

5.14 Teva pharmaceutical Industries Ltd.

5.14.1 Teva pharmaceutical Industries Ltd. Company Profile (Company Name, Major Business, Plants Distribution, Sales Region, Contact Information)

5.14.2 Teva pharmaceutical Industries Ltd. Sales, Growth Rate and Global Market Share from 2014-2020

5.15 Novartis Pharmaceuticals

5.15.1 Novartis Pharmaceuticals Company Profile (Company Name, Major Business, Plants Distribution, Sales Region, Contact Information)

5.15.2 Novartis Pharmaceuticals Sales, Growth Rate and Global Market Share from 2014-2020

6. Investment Analysis

6.1 Fundamental Analysis (Porter's Five Forces Analysis)

6.2 Technical Preparation Analysis

6.3 Risk Evaluating Analysis

6.4 Estimated Investment Pay-Back Period

7. Future Forecast of the Global Fabry Disease Therapeutic Market from 2021-2026

7.1 Future Forecast of Global Fabry Disease Therapeutic Market from 2021-2026 Segment by Region

7.2 Future Forecast of the Global Fabry Disease Therapeutic Market from 2021-2026 Segment by Types

7.3 Future Forecast of the Global Fabry Disease Therapeutic Market from 2021-2026 Segment by End-User/Applications

8 Appendix

8.1 Discussion Guide

8.2 Related Reports

8.3 Author List

9 Disclaimer

List of Tables and Figures

Global Fabry Disease Therapeutic Market Value ($) and Growth Rate of Fabry Disease Therapeutic from 2014-2026

Global Fabry Disease Therapeutic Production and Growth Rate Segment by Product Types from 2014-2026F

Global Fabry Disease Therapeutic Consumption and Growth Rate Segment by End-User/Application from 2014-2026E

Table Driving Factors for this Market (North America, Europe, Asia-Pacific, Latin America, Middle East & Africa)

Table Global Fabry Disease Therapeutic Production and Growth Rate Segment by Product Types from 2014-2020

Table Global Fabry Disease Therapeutic Value ($) and Growth Rate Segment by Product Types from 2014-2020

Figure Enzyme Replacement Therapy of Fabry Disease Therapeutic

Figure Alternative therapies of Fabry Disease Therapeutic

Table Global Fabry Disease Therapeutic Consumption and Growth Rate Segment by End-User/Application from 2014-2020

Table Global Fabry Disease Therapeutic Value ($) and Growth Rate Segment by End-User/Application from 2014-2020

Figure Hospitals of Fabry Disease Therapeutic

Figure Clinics of Fabry Disease Therapeutic

Figure Others of Fabry Disease Therapeutic

Table Global Fabry Disease Therapeutic Production Value ($) by Regions

Table Global Fabry Disease Therapeutic Production Value Share by Regions

Table Global Fabry Disease Therapeutic Production by Regions

Table Global Fabry Disease Therapeutic Production Share by Regions

Table Global Fabry Disease Therapeutic Consumption by Regions

Table Global Fabry Disease Therapeutic Consumption Share by Regions

Figure North America Fabry Disease Therapeutic Production and Growth Rate from 2014-2020

Figure North America Fabry Disease Therapeutic Consumption and Growth Rate from 2014-2020

Table North America Fabry Disease Therapeutic Import and Export from 2014-2020

Table North America Fabry Disease Therapeutic Value ($) and Growth (%) by Type from 2019-2020

Table North America Fabry Disease Therapeutic Value ($) and Growth (%) by Application from 2019-2020

Table North America Fabry Disease Therapeutic Value ($) and Growth (%) by Countries from 2019-2020

Table Top North America Fabry Disease Therapeutic Participants Value ($) and Market Share (%) in 2019

Figure Europe Fabry Disease Therapeutic Production and Growth Rate from 2014-2020

Figure Europe Fabry Disease Therapeutic Consumption and Growth Rate from 2014-2020

Table Europe Fabry Disease Therapeutic Import and Export from 2014-2020

Table Europe Fabry Disease Therapeutic Value ($) and Growth (%) by Type from 2019-2020

Table Europe Fabry Disease Therapeutic Value ($) and Growth (%) by Application from 2019-2020

Table Europe Fabry Disease Therapeutic Market Value ($) and Growth (%) by Countries from 2019-2020

Table Top Europe Fabry Disease Therapeutic Participants Value ($) and Market Share (%) in 2019

Figure Asia-Pacific Fabry Disease Therapeutic Production and Growth Rate from 2014-2020

Figure Asia-Pacific Fabry Disease Therapeutic Consumption and Growth Rate from 2014-2020

Table Asia-Pacific Fabry Disease Therapeutic Import and Export from 2014-2020

Table Asia-Pacific Fabry Disease Therapeutic Value ($) and Growth (%) by Type from 2019-2020

Table Asia-Pacific Fabry Disease Therapeutic Value ($) and Growth (%) by Application from 2019-2020

Table Asia-Pacific Fabry Disease Therapeutic Value ($) and Growth (%) by Countries from 2019-2020

Table Top Asia-Pacific Fabry Disease Therapeutic Participants Value ($) and Market Share (%) in 2019

Figure Latin America Fabry Disease Therapeutic Production and Growth Rate from 2014-2020

Figure Latin America Fabry Disease Therapeutic Consumption and Growth Rate from 2014-2020

Table Latin America Fabry Disease Therapeutic Import and Export from 2014-2020

Table Latin America Fabry Disease Therapeutic Value ($) and Growth (%) by Type from 2019-2020

Table Latin America Fabry Disease Therapeutic Value ($) and Growth (%) by Application from 2019-2020

Table Latin America Fabry Disease Therapeutic Value ($) and Growth (%) by Countries from 2019-2020

Table Top Latin America Fabry Disease Therapeutic Participants Value ($) and Market Share (%) in 2019

Figure Middle East & Africa Fabry Disease Therapeutic Production and Growth Rate from 2014-2020

Figure Middle East & Africa Fabry Disease Therapeutic Consumption and Growth Rate from 2014-2020

Table Middle East & Africa Fabry Disease Therapeutic Import and Export from 2014-2020

Table Middle East & Africa Fabry Disease Therapeutic Value ($) and Growth (%) by Type from 2019-2020

Table Middle East & Africa Fabry Disease Therapeutic Value ($) and Growth (%) by Application from 2019-2020

Table Middle East & Africa Fabry Disease Therapeutic Value ($) and Growth (%) by Countries from 2019-2020

Table Top Middle East & Africa Fabry Disease Therapeutic Participants Value ($) and Market Share (%) in 2019

Table Bristol-Myers Squibb Company Company Profile (Company Name, Major Business, Plants Distribution, Sales Region, Contact Information)

Figure Bristol-Myers Squibb Company Sales and Growth Rate from 2014-2020

Figure Bristol-Myers Squibb Company Revenue ($), Gross Margin and Global Market Share from 2014-2020

Table AbbVie Inc. Company Profile (Company Name, Major Business, Plants Distribution, Sales Region, Contact Information)

Figure AbbVie Inc. Sales and Growth Rate from 2014-2020

Figure AbbVie Inc. Revenue ($), Gross Margin and Global Market Share from 2014-2020

Table Takeda Pharmaceutical Co. Ltd. Company Profile (Company Name, Major Business, Plants Distribution, Sales Region, Contact Information)

Figure Takeda Pharmaceutical Co. Ltd. Sales and Growth Rate from 2014-2020

Figure Takeda Pharmaceutical Co. Ltd. Revenue ($), Gross Margin and Global Market Share from 2014-2020

Table Shire Company Profile (Company Name, Major Business, Plants Distribution, Sales Region, Contact Information)

Figure Shire Sales and Growth Rate from 2014-2020

Figure Shire Revenue ($), Gross Margin and Global Market Share from 2014-2020

Table Green Cross Corp. Company Profile (Company Name, Major Business, Plants Distribution, Sales Region, Contact Information)

Figure Green Cross Corp. Sales and Growth Rate from 2014-2020

Figure Green Cross Corp. Revenue ($), Gross Margin and Global Market Share from 2014-2020

Table Protalix Company Profile (Company Name, Major Business, Plants Distribution, Sales Region, Contact Information)

Figure Protalix Sales and Growth Rate from 2014-2020

Figure Protalix Revenue ($), Gross Margin and Global Market Share from 2014-2020

Table Amicus therapeutics Company Profile (Company Name, Major Business, Plants Distribution, Sales Region, Contact Information)

Figure Amicus therapeutics Sales and Growth Rate from 2014-2020

Figure Amicus therapeutics Revenue ($), Gross Margin and Global Market Share from 2014-2020

Table Amgen Inc. Company Profile (Company Name, Major Business, Plants Distribution, Sales Region, Contact Information)

Figure Amgen Inc. Sales and Growth Rate from 2014-2020

Figure Amgen Inc. Revenue ($), Gross Margin and Global Market Share from 2014-2020

Table Sanofi-Aventis LLC Company Profile (Company Name, Major Business, Plants Distribution, Sales Region, Contact Information)

Figure Sanofi-Aventis LLC Sales and Growth Rate from 2014-2020

Figure Sanofi-Aventis LLC Revenue ($), Gross Margin and Global Market Share from 2014-2020

Table Merck & Co. Company Profile (Company Name, Major Business, Plants Distribution, Sales Region, Contact Information)

Figure Merck & Co. Sales and Growth Rate from 2014-2020

Figure Merck & Co. Revenue ($), Gross Margin and Global Market Share from 2014-2020

Table GlaxoSmithKline plc Company Profile (Company Name, Major Business, Plants Distribution, Sales Region, Contact Information)

Figure GlaxoSmithKline plc Sales and Growth Rate from 2014-2020

Figure GlaxoSmithKline plc Revenue ($), Gross Margin and Global Market Share from 2014-2020

Table Genzyme-Sanofi Company Profile (Company Name, Major Business, Plants Distribution, Sales Region, Contact Information)

Figure Genzyme-Sanofi Sales and Growth Rate from 2014-2020

Figure Genzyme-Sanofi Revenue ($), Gross Margin and Global Market Share from 2014-2020

Table Pfizer Company Profile (Company Name, Major Business, Plants Distribution, Sales Region, Contact Information)

Figure Pfizer Sales and Growth Rate from 2014-2020

Figure Pfizer Revenue ($), Gross Margin and Global Market Share from 2014-2020

Table Teva pharmaceutical Industries Ltd. Company Profile (Company Name, Major Business, Plants Distribution, Sales Region, Contact Information)

Figure Teva pharmaceutical Industries Ltd. Sales and Growth Rate from 2014-2020

Figure Teva pharmaceutical Industries Ltd. Revenue ($), Gross Margin and Global Market Share from 2014-2020

Table Novartis Pharmaceuticals Company Profile (Company Name, Major Business, Plants Distribution, Sales Region, Contact Information)

Figure Novartis Pharmaceuticals Sales and Growth Rate from 2014-2020

Figure Novartis Pharmaceuticals Revenue ($), Gross Margin and Global Market Share from 2014-2020

Table Global Fabry Disease Therapeutic Value ($) and Growth Rate Forecast by Regions (2021-2026)

Table Global Fabry Disease Therapeutic Production and Growth Rate Forecast by Regions (2021-2026)

Table Global Fabry Disease Therapeutic Consumption and Growth Rate Forecast by Regions (2021-2026)

Table Global Fabry Disease Therapeutic Production and Growth Rate Forecast by Types (2021-2026)

Table Global Fabry Disease Therapeutic Consumption and Growth Rate Forecast by End-User/Applications (2021-2026)

 
Purchase Options

* Taxes/Fees, If applicable will be
added during checkout. All prices in USD.

Need More Information

Contact Us

+ 1-888-961-4454

Drop Us an email at

help@bigmarketresearch.com

Similar Reports

United States Pneumococcal & Meningococcal Vaccines Market by Company Profile, Deals Type, Brand Analysis, Share, Key Trends & Opportunities to 2025

The United States pneumococcal & meningococcal vaccines market is set to surpass US$ 7.5 Million by the year end of 2025. “United States Pneumococcal & Meningococcal Vaccines Market by Company Profile, Deals Type, Brand Analysis, Share, Key Trends & Opportunities to 2025” presents an in–depth assessment of the United States pneumococcal & meningococcal vaccines market dynamics, opportunitie...

  • Publish Date: June 24, 2019
  • $1050
Global Human Immunodeficiency Virus (HIV) Drugs Market 2019 – 2025: Top 22 Drugs Analysis, Key Trends, Players and Forecasts

The global human immunodeficiency virus (HIV) drugs market size is expected to surpass US$ 30 billion by 2025. “Global Human Immunodeficiency Virus (HIV) Drugs Market 2019 – 2025: Top 22 Drugs Analysis, Key Trends, Players and Forecasts” presents an in-depth assessment of the global human immunodeficiency virus (HIV) drugs market dynamics, opportunities, future roadmap, competitive landscap...

  • Publish Date: February 18, 2019
  • $1290
Global Blockbuster Drugs Market 2015 - 2025: Top 50 Drugs Analysis, Deal Trends, Players and Forecasts

The global 50 blockbuster drugs market size is estimated to reach a value of US$ 292 billion by 2025. ‘’Global Blockbuster Drugs Market 2015 - 2025: Top 50 Drugs Analysis, Deal Trends, Players and Forecasts” presents an in-depth assessment of the global blockbuster drugs market dynamics, opportunities, future roadmap, competitive landscape and discusses major trends. The report offers the m...

  • Publish Date: December 11, 2018
  • $1390